Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
450 participants
OBSERVATIONAL
2015-06-23
2040-06-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Athletes
1. Males and females aged 14-23 years old
2. Athletes competing in endurance sports at national or international level for at least 2 years. Sports include:
1. Triathlon
2. Cycling
3. Distance running (≥ 1500 meters)
4. Rowing
5. Swimming
No intervention
No intervention
Non-athletes
1. Males and females aged 14-23 years old
2. Non athletes engaged in \< 3 hours per week of physical activity
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Athletes competing in endurance sports at national or international level for at least 2 years. Sports include:
1. Triathlon
2. Cycling
3. Distance running (≥ 1500 meters)
4. Rowing
5. Swimming
3. Non athletes engaged in \< 3 hours per week of physical activity
Exclusion Criteria
2. Current smoker of past history of smoking
3. Diabetes mellitus
14 Years
23 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baker Heart and Diabetes Institute
OTHER
Victor Chang Cardiac Research Institute
UNKNOWN
University Hospital, Antwerp
OTHER
Jessa Hospital
OTHER
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
dr. Guido Claessen
Chair
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guido Claessen, Prof. Dr.
Role: STUDY_CHAIR
UZ Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baker Heart and Diabetes Institute
Melbourne, Victoria, Australia
UZ Antwerpen
Edegem, Antwerp, Belgium
Jessa Ziekenhuis Hasselt
Hasselt, Limburg, Belgium
UZ Leuven
Leuven, Vlaams Brabants, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
K Janssens
Role: primary
Andre La Gerche, Prof. Dr.
Role: backup
Hein Heidbuchel, Prof. Dr.
Role: primary
Caroline Van De Heyning, Prof. Dr.
Role: backup
Lieven Herbots, Dr.
Role: primary
Olivier Ghekiere, Dr.
Role: backup
Guido Claessen, Prof. Dr.
Role: primary
Rik Willems, Prof. Dr.
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
De Bosscher R, Dausin C, Janssens K, Bogaert J, Elliott A, Ghekiere O, Van De Heyning CM, Sanders P, Kalman J, Fatkin D, Herbots L, Willems R, Heidbuchel H, La Gerche A, Claessen G; Pro@Heart Consortium. Rationale and design of the PROspective ATHletic Heart (Pro@Heart) study: long-term assessment of the determinants of cardiac remodelling and its clinical consequences in endurance athletes. BMJ Open Sport Exerc Med. 2022 Mar 18;8(1):e001309. doi: 10.1136/bmjsem-2022-001309. eCollection 2022.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
57241
Identifier Type: -
Identifier Source: org_study_id